clearn.png
Monday October 18th, 2021 4:02AM

Guided Therapeutics Receives New Half Million Dollar Purchase Order from China

By The Associated Press

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Jan 5, 2021--

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today that it had received a new purchase order in the amount of $530,695 from its Chinese co-manufacturing partner and distributor for China, Shandong Yaohua Medical Instrument Corporation (SMI). The new purchase order, which was issued by SMI based on its progress with the Chinese FDA for approval of LuViva, stipulates a 10% down payment in January 2021 with the balance to be paid in May 2021. This new order is in addition to an existing larger order of $2.5 Million, a quarter of which is due upon filing an application with the Chinese FDA and the balance due upon approval by Chinese FDA. The filing is expected in the third quarter of 2021 with approval expected early in 2022.

“We are extremely pleased with the progress that we are making with SMI in China, the world’s second largest medical device market,” said Gene Cartwright, CEO of Guided Therapeutics. “The new purchase order is tangible evidence that SMI is working its way toward approval of LuViva in China. We feel confident in forecasting that revenues from China alone in 2021 will exceed a million dollars.”

According to the World Health Organization, cervical cancer is ranked as one of the most frequent cancers in women in the world and in China it is the second most common cancer among women. China has a population of approximately 560 million women above 15 years of age, who are at risk of developing cervical cancer. Current estimates indicate approximately 100,000 new cases of cervical cancer are diagnosed each year and 30,000 deaths occur annually due to cervical cancer in China.

Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company’s first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit: .

Forward-Looking Statements Disclaimer: A number of the matters and subject areas discussed in this news release that are not historical or current facts deal with potential future circumstances and developments. The discussion of such matters and subject areas is qualified by the inherent risks and uncertainties surrounding future expectations generally and also may materially differ from Guided Therapeutics’ actual future experience involving any of or more of such matters and subject areas. Such risks and uncertainties include those related to the early stage of commercialization of products, the uncertainty of market acceptance of products, the uncertainty of development or effectiveness of distribution channels, the intense competition in the medical device industry, the sufficiency of capital raised in prior financings and the ability to realize their expected benefits, the uncertainty of future capital to develop products or continue as a going concern, the uncertainty of regulatory approval of products, and the dependence on licensed intellectual property, as well as those that are more fully described from time to time under the heading “Risk Factors” in Guided Therapeutics’ reports filed with the SEC, including Guided Therapeutics’ Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and subsequent filings.

View source version on businesswire.com:

CONTACT: Mark Faupel

Guided Therapeutics

770-242-8723

KEYWORD: CHINA UNITED STATES NORTH AMERICA ASIA PACIFIC GEORGIA

INDUSTRY KEYWORD: BIOTECHNOLOGY FDA HEALTH GENERAL HEALTH HEALTHCARE REFORM ONCOLOGY OTHER SCIENCE MEDICAL DEVICES PUBLIC POLICY/GOVERNMENT SCIENCE CLINICAL TRIALS

SOURCE: Guided Therapeutics, Inc.

Copyright Business Wire 2021.

PUB: 01/05/2021 09:05 AM/DISC: 01/05/2021 09:06 AM

http://www.businesswire.com/news/home/20210105005050/en

  • Associated Categories: Associated Press (AP), AP Health, AP Business, AP Business - Corporate News, AP Online - Georgia News, AP Business Wire - Georgia, AP Health - Women's health, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
EXPLAINER: Why the smallest state has a big virus challenge
Rhode Island emerged as a surprising COVID-19 hot spot last month, briefly posting the highest rate of new cases in the country
9:11AM ( 20 minutes ago )
Pandemic haunts new year as virus growth outpaces vaccines
Despite growing vaccine access, January is looking grim around the globe as the virus resurges and reshapes itself from Britain to Japan to California
9:04AM ( 27 minutes ago )
It's lockdown No. 3 for England, at least six weeks at home
England is entering a third national lockdown that will last at least six weeks, as authorities struggle to stem a surge in COVID-19 infections that threatens to overwhelm hospitals around the U.K. Prime Minister Boris Johnson has announced a tough new stay-at-home order for England until at least mid-February to combat a new, more contagious coronavirus variant
8:56AM ( 35 minutes ago )
Associated Press (AP)
Just 1% of Californians immunized amid slow vaccine rollout
Distribution hiccups and logistical challenges have slowed the initial coronavirus vaccine rollout in California
7:15AM ( 2 hours ago )
Masks, tests, batches: Locked-down Greece swears in Cabinet
Greece’s new Cabinet is being sworn in at three separate ceremonies to comply with national lockdown restrictions
6:56AM ( 2 hours ago )
The Latest: Danes: Up to 6-week delay OK for 2nd shot
Danish health authorities will allow a wait of up to six weeks before administering a second dose of a coronavirus vaccine, but say the original guidelines of waiting only three to four weeks to deliver a second shot should be followed whenever possible
5:47AM ( 3 hours ago )
AP Health
Qatar ruler lands in Saudi Arabia for summit to end blockade
Qatar’s ruling emir has arrived in Saudi Arabia to attend a high-level summit of Arab leaders, following an announcement that the kingdom would end its yearslong embargo on the tiny Gulf state
7:55AM ( 1 hour ago )
Stocks turn lower as virus cases rise, countries lock down
Global shares have turned lower as more countries impose restrictions on public life to cope with a stubborn increase in coronavirus infections
7:54AM ( 1 hour ago )
Decision day in Georgia with Senate majority at stake
Georgia voters are set to decide the balance of power in Congress in a pair of high-stakes Senate runoff elections
7:46AM ( 1 hour ago )
AP Business
Where is Jack Ma, China's e-commerce pioneer?
China’s best-known entrepreneur, e-commerce billionaire Jack Ma, hasn't been seen in public since he angered regulators with an October speech
5:09AM ( 4 hours ago )
The Latest: Mexico approves Oxford-AstraZeneca vaccine
Mexico has approved the Oxford-AstraZeneca coronavirus vaccine for emergency use, hoping to spur a halting vaccination effort that has only given about 44,000 shots since the third week of December, about 82% of the doses the country has received
9:16PM ( 12 hours ago )
Stocks fall as trading starts for year of great expectations
U.S. stocks are closing lower Monday as big swings return to Wall Street to start a year when the dominant expectation is for a powerful economic rebound to sweep the world
6:34PM ( 14 hours ago )
AP Business - Corporate News
Analysis: With call, Trump shows no limit to his power grab
President Donald Trump’s ongoing efforts to overturn the 2020 election results — laid out in stark detail in an hourlong weekend phone call with a Georgia election official — are demonstrating his determination to maintain a grip on power no matter the consequences
7:00AM ( 2 hours ago )
Randle scores 28, Rivers' 3 helps Knicks beat Hawks 113-108
Julius Randle scored 28 points and grabbed 17 rebounds, Austin Rivers hit a huge 3-pointer and the New York Knicks rallied to beat the Atlanta Hawks 113-108
11:19PM ( 10 hours ago )
Biden, Trump warn of high stakes of Georgia Senate runoffs
President-elect Joe Biden on Monday told Georgia Democrats they had the power to “chart the course” for a generation as President Donald Trump urged Republican voters to “swamp” the polls ahead of runoff elections that will determine control of the U.S. Senate
11:07PM ( 10 hours ago )
AP Online - Georgia News
AP Business Wire - Georgia
AP Health - Women's health
Iran spokesman slams South Korea over frozen assets
An Iranian government spokesman has called South Korea a “hostage taker” over freezing Tehran’s $7 billion in assets there
4:46AM ( 4 hours ago )
Asian stocks mixed after Wall St retreat as virus cases rise
Asian shares are mixed as Japanese shares echoed pullbacks on Wall Street while other regional indexes recouped earlier losses amid continuing worries about surging coronavirus cases
2:02AM ( 7 hours ago )
Asian stocks track Wall St retreat as COVID caseloads surge
Asian shares are mostly lower, tracking pullbacks on Wall Street, as worries grow about surging coronavirus cases in the region
10:19PM ( 11 hours ago )
AP Business - Industries
France's go-slow coronavirus vaccination strategy backfires
France’s cautious approach to its virus vaccine rollout appears to have backfired
1:50PM ( 19 hours ago )
The Latest: Scotland to enter full lockdown from Tuesday
Scottish leader Nicola Sturgeon says that from Tuesday, people in Scotland are legally required to stay at home except for essential reasons to curb a renewed surge of coronavirus infections
10:48AM ( 22 hours ago )
Stocks dip as trading starts for year of great expectations
U.S. stocks are holding close to their record levels Monday, as trading gets underway for a year where the dominant expectation is that a powerful economic rebound will sweep the world
10:09AM ( 23 hours ago )
AP Business - Health Care
EXPLAINER: Why the smallest state has a big virus challenge
Rhode Island emerged as a surprising COVID-19 hot spot last month, briefly posting the highest rate of new cases in the country
9:11AM ( 20 minutes ago )
Pandemic haunts new year as virus growth outpaces vaccines
Despite growing vaccine access, January is looking grim around the globe as the virus resurges and reshapes itself from Britain to Japan to California
9:04AM ( 27 minutes ago )
It's lockdown No. 3 for England, at least six weeks at home
England is entering a third national lockdown that will last at least six weeks, as authorities struggle to stem a surge in COVID-19 infections that threatens to overwhelm hospitals around the U.K. Prime Minister Boris Johnson has announced a tough new stay-at-home order for England until at least mid-February to combat a new, more contagious coronavirus variant
8:56AM ( 35 minutes ago )
Siegfried, meet Ahmet: German weather systems get makeover
Move over, Siegfried
8:51AM ( 40 minutes ago )
Prosecutor: Wisconsin pharmacist thought vaccine was unsafe
Court documents show that a Wisconsin pharmacist told police he tried to ruin hundreds of doses of coronavirus vaccine because he believed the shots would mutate people's DNA
8:44AM ( 48 minutes ago )